• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?

作者信息

Lu Ligong, Jiang Jun, Zhan Meixiao, Zhang Hui, Wang Qian-Ting, Sun Sheng-Nan, Guo Xiao-Kai, Yin Hua, Wei Yadong, Liu Jun O, Li Shi-You, Li Yong, He You-Wen

机构信息

Zhuhai Interventional Medical Center, Zhuhai Precision Medical Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, P.R. China.

Tricision Biotherapeutic Inc., Zhuhai, P.R. China.

出版信息

Hepatology. 2021 Jan;73(1):414-421. doi: 10.1002/hep.31279.

DOI:10.1002/hep.31279
PMID:32299136
Abstract
摘要

相似文献

1
Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?靶向肝细胞癌新抗原进行免疫治疗：一种徒劳的策略？
Hepatology. 2021 Jan;73(1):414-421. doi: 10.1002/hep.31279.
2
Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma.癌-睾丸抗原在肝细胞癌免疫治疗中的应用。
Immunotherapy. 2018 Apr;10(5):411-421. doi: 10.2217/imt-2017-0154.
3
[What are the limits of efficacy for immunotherapy against hepatocellular carcinoma and its clinical availability].[肝癌免疫治疗的疗效极限及其临床可用性是什么]
Zhonghua Gan Zang Bing Za Zhi. 2014 May;22(5):393-6. doi: 10.3760/cma.j.issn.1007-3418.2014.06.001.
4
Cancer vaccines for hepatocellular carcinoma: future directions.用于肝细胞癌的癌症疫苗：未来方向
Immunotherapy. 2016;8(4):391-3. doi: 10.2217/imt-2015-0018.
5
Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.肝细胞癌免疫治疗中靶向肿瘤相关抗原：过去的困境与未来策略
Hepatology. 2021 Feb;73(2):821-832. doi: 10.1002/hep.31502.
6
Potential of immunotherapy for hepatocellular carcinoma.免疫疗法治疗肝细胞癌的潜力。
J Hepatol. 2011 Apr;54(4):830-4. doi: 10.1016/j.jhep.2010.10.013. Epub 2010 Nov 9.
7
Immunotherapy in hepatocellular carcinoma.肝细胞癌的免疫治疗。
Ann Hepatol. 2019 Mar-Apr;18(2):291-297. doi: 10.1016/j.aohep.2019.04.003. Epub 2019 Apr 25.
8
T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.T细胞相关免疫疗法：一种治疗肝细胞癌的有前景的策略。
Immunotherapy. 2017 Jun;9(7):523-525. doi: 10.2217/imt-2017-0053.
9
Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.使用抗肝癌相关抗原的单克隆抗体对肝细胞癌进行肿瘤部位定向治疗。
Prog Liver Dis. 1993;11:251-67.
10
[Status and prospect of antibody-directed targeting treatment for hepatocellular carcinoma].[肝细胞癌抗体导向靶向治疗的现状与展望]
Zhonghua Gan Zang Bing Za Zhi. 2005 May;13(5):380-1.

引用本文的文献

1
Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment.个性化免疫：基于新抗原的疫苗正在彻底改变肝细胞癌的治疗方式。
Cancers (Basel). 2025 Jan 23;17(3):376. doi: 10.3390/cancers17030376.
2
A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma.一种基于KIF20A的热敏水凝胶疫苗可有效增强肝细胞癌的免疫检查点阻断疗法。
NPJ Vaccines. 2025 Jan 3;10(1):1. doi: 10.1038/s41541-024-01060-2.
3
COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome.
基于 COSMIC 的突变数据库提高了 HLA-I 免疫肽组的鉴定效率。
J Transl Med. 2024 Feb 10;22(1):144. doi: 10.1186/s12967-023-04821-0.
4
Autophagy, Oxidative Stress, and Alcoholic Liver Disease: A Systematic Review and Potential Clinical Applications.自噬、氧化应激与酒精性肝病：一项系统综述及潜在临床应用
Antioxidants (Basel). 2023 Jul 14;12(7):1425. doi: 10.3390/antiox12071425.
5
Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen.通过共表达患者 HLA 和抗原的单质粒系统验证肝细胞癌中的优势新抗原。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-006334.
6
Immunotargeting of Cancer Stem Cells.癌症干细胞的免疫靶向治疗
Cancers (Basel). 2023 Mar 5;15(5):1608. doi: 10.3390/cancers15051608.
7
PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.PGNneo：基于蛋白质基因组学的非编码区新抗原预测管道。
Cells. 2023 Mar 1;12(5):782. doi: 10.3390/cells12050782.
8
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.用于预测肝细胞癌预后和治疗结果的肿瘤突变负荷
Int J Mol Sci. 2023 Feb 8;24(4):3441. doi: 10.3390/ijms24043441.
9
Pathogenesis to management of hepatocellular carcinoma.肝细胞癌从发病机制到治疗
Genes Cancer. 2022 Dec 13;13:72-87. doi: 10.18632/genesandcancer.226. eCollection 2022.
10
Neoantigens and their clinical applications in human gastrointestinal cancers.新抗原及其在人类胃肠道癌症中的临床应用。
World J Surg Oncol. 2022 Sep 29;20(1):321. doi: 10.1186/s12957-022-02776-y.